Search

everythinglearnresearchcommunity

for

Search:↓

Ecklonia cava improves the effectiveness of Diane-35 in managing PCOS symptoms.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Hair loss may increase heart disease risk.

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Menopause can cause skin issues, and seeing a dermatologist helps.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Polycystic Ovary Syndrome (PCOS) is a hormonal disorder in women that can cause infertility and other health issues, and it may be improved by treatments that increase insulin sensitivity.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

DHT, a testosterone byproduct, causes male pattern baldness.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

The document explains how the male reproductive system works, its role in making testosterone, and how conditions like obesity can disrupt it, leading to low testosterone and fertility issues.

Spironolactone can reduce hair growth in women with hirsutism.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.